Shareholder letter - Tuesday February 17, 2015
Link to document.
RegeneRx Biopharmaceuticals, Inc. is a clinical-stage drug development company focused on tissue protection, repair and regeneration with an extensive portfolio of product candidates for first-in-class therapeutic peptides.
February 25, 2015
RegeneRx Receives Israeli Patent for Treating and Repairing Heart Damage
February 19, 2015
RegeneRx Updates Website